Is a complete EVGN research report available?

No complete published report is available for Evogene Ltd. (EVGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Evogene Ltd. (EVGN)

NASDAQ: EVGN · USD

$0.49

+0.01 (+1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EVGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.4M
Revenue (ttm)	1.8M
Net income (ttm)	-11.8M
EPS (ttm)	-$1.37
Shares out	10.4M
Volume	70,982
Beta	0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.8M
Net income (ttm): -11.8M
EPS (ttm): -$1.37
Market cap: 5.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EVGN indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001574565
Company name	Evogene Ltd.
Country	Israel
Country code	US
Cusip	M4119S104
Employees	52
Employees Change	-65%
Employees Change Percent	-55.56
Enterprise value	$4.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	IL0011050551
Last refreshed	2026-07-31
Market cap	$5.4M
Market cap category	Nano-Cap
Price	$0.49
Price currency	USD
Rev Per Employee	35,461.54x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2870
Symbol	EVGN
Website	https://www.evogene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-219.53%
EV Sales Forward	4.23x
EV/Sales	2.64x
FCF yield	-210.62%
P/B ratio	0.67x
P/S ratio	2.91x
PS Forward	4.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-767.73%
EBITDA Margin	-711.55%
Gross margin	-46.8%
Gross Profit	$-863,000
Gross Profit Growth Q	-75.42%
Net Income	$-11.8M
Net Income Growth Years	4%
Pretax Margin	-949.08%
Profit Per Employee	$-226,308
ROA	-32.89
Roa5y	-26.27
ROCE	-112.5
ROE	-171.8
Roe5y	-69.88
ROIC	-68.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-39.02%
Cagr15y	-26.72%
Cagr1y	-60.87%
Cagr3y	-63.89%
Cagr5y	-55.59%
EPS Growth Years	5
Revenue Growth	-72.74x
Revenue Growth Q	-86.33x
Revenue Growth Years	0x
Revenue Growth3 Y	-3.92x
Revenue Growth5 Y	7.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$17.9M
Cash	$13.1M
Current Assets	$15M
Current Liabilities	$5.4M
Debt	$2M
Debt Equity	$0.25
Equity	$8M
Interest Coverage	-3.89
Liabilities	$10M
Long Term Assets	$3M
Long Term Liabilities	$4.6M
Net Cash	$11M
Net Cash By Market Cap	$206
Net Cash Growth	51.89%
Net Debt Equity	$-1.38
Tangible Book Value	$-2.5M
Tangible Book Value Per Share	$-0.24
WACC	45.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Inventory Turnover	2.33
Net Working Capital	$-2.8M
Quick ratio	2.75
Working Capital	$9.6M
Working Capital Turnover	$0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.29%
1Y total return	-60.85%
200-day SMA	0.88
3Y total return	-95.29%
50-day SMA	0.55
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.27%
All Time High	203.9
All Time High Change	-99.76%
All Time High Date	2013-12-12
All Time Low	0.37
All Time Low Change	32.27%
All Time Low Date	2026-06-26
ATR	0.05
Beta	0.78
Ch YTD	-55.51
High	0.51
High52	1.5
High52 Date	2025-10-08
High52ch	-67.37%
Low	0.47
Low52	0.37
Low52 Date	2026-06-26
Low52ch	32.27%
Ma50ch	-11.5%
Premarket Change Percent	1.31
Premarket Price	$0.49
Premarket Volume	1,632
Price vs 200-day SMA	-44.29%
RSI	44.38
RSI Monthly	31.23
RSI Weekly	34.26
Sharpe ratio	-1.05x
Sortino ratio	-1.46
Tr YTD	-55.51
Tr15y	-99.06%
Tr1m	13.45%
Tr1w	-9.82%
Tr3m	-35.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.27
Earnings Revenue Estimate	325,000x
Earnings Revenue Estimate Growth	-63.24x
Operating Income	$-13.8M
Operating margin	-745.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,328,878%
Float Percent	99.19%
Net Borrowing	-501,000
Shares Insiders	0.81%
Shares Institutions	6.13%
Shares Out	10,412,764
Shares Qo Q	11.7%
Shares Yo Y	40.53%
Short Ratio	0.07
Short Shares	2.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.7M
Adjusted OCF	-11,681,000
Average Volume	1,969,081.1x
Bv Per Share	-0.24
CAPEX	$-16,000
Ch10y	-99.29
Ch15y	-99.06
Ch1m	13.45
Ch1w	-9.82
Ch1y	-60.85
Ch3m	-35.45
Ch3y	-95.29
Ch5y	-98.27
Ch6m	-51.54
Change	1.6%
Change From Open	-4.04
Close	0.48
Days Gap	5.88
Depreciation Amortization	416,000
Dollar Volume	34,738.6
Earnings Date	2026-08-18
Earnings Time	bmo
EBIT	$-14.2M
EBITDA	$-13.1M
EPS	$-1.37
F Score	2
FCF	$-11.3M
FCF EV Yield	-232.3x
FCF Per Share	$-1.08
Financing CF	-3,450,000
Fiscal Year End	December
Founded	1,999
Income Tax	$5,000
Investing CF	15,697,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-20
Last Report Date	2026-03-31
Last Split Date	2024-07-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	0.78
Ma150ch	-37.42%
Ma20	0.51
Ma20ch	-3.62%
Net CF	1,016,000
Next Earnings Date	2026-08-18
Open	0.51
Optionable	No
Position In Range	50.72
Post Close	0.49
Postmarket Change Percent	0.12
Postmarket Price	$0.49
Ppne	2,409,000
Pre Close	0.48
Price Date	2026-07-30
Relative Volume	0.04x
Revenue	1,844,000x
SBC By Revenue	22.07x
Share Based Comp	407,000
Tax By Revenue	0.27x
Tr6m	-51.54%
Volume	70,982
Z Score	-23.7

Evogene Ltd. (EVGN)

Coverage state: Market snapshot only — no published research

Generate the first EVGN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · EVGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EVGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EVGN

Frequently asked questions